Medical eponyms, or conditions that are named after former physician leaders and experts in medicine, often have dark roots — and although their continued phase-out is supported by top medical groups including the American Psychiatric Association and the World Health Organization, some experts argue against this, The New York Times reported June 19.
Read the full post on Becker's Hospital Review - Healthcare News
